Next wave of innovation in Alzheimer’s disease therapeutics: The value of novel active transport mechanisms

Abstract

Background: The positive study results and approvals for first‐generation anti‐amyloid‐beta (Aβ)‐targeting therapies are an important advancement in the treatment of Alzheimer’s disease (AD), offering new hope for people living with AD and important learnings for the field.

The paper